Lindsay A. Abraham, JD, CIP
Regulatory Chair Director
Biography
Lindsay Abraham, JD, CIP, is a regulatory chair director at WCG’s IRB and has over 13 years of experience in the clinical research field, specifically the IRB space.
Lindsay chairs Board meetings and provides guidance to the Board and clients regarding the interpretation of federal and state laws pertaining to IRB operations and functions. Lindsay also presents education and training courses for Board members and staff.
Prior to joining WCG in 2010, Lindsay practiced in the field of family law and holds a Juris Doctorate from Seattle University School of Law.
Latest insights by Lindsay
WCG Clinical | Insights
Technology Focus: The Use of AI in Consent Form Development
Blog Posts
WCG Clinical | Insights
What Is Expedited Review?
Blog Posts
WCG Clinical | Insights
Post Study Activities Requiring IRB Review
Blog Posts
WCG Clinical | Insights
What documentation needs to be submitted to the IRB for an IND exemption request?
Blog Posts
WCG Clinical | Insights
Should Consent Form updates be aligned with Investigator Brochure updates, or wait for next Protocol amendment?
Blog Posts
WCG Clinical | Insights
Questions on the FDA’s 30-Day IND Review Period and IRB Approval
Blog Posts
WCG Clinical | Insights
If a Subject’s Care Is Divided Equally Between Two Caregivers, Who Should Sign Caregiver Consent?
Blog Posts
WCG Clinical | Insights
Do we need to submit safety events from another site to our IRB?
Blog Posts
WCG Clinical | Insights
What are the IRB submission requirements for observational studies?
Blog Posts
WCG Clinical | Insights